TY - JOUR
T1 - Hospital-acquired complications
T2 - the relative importance of hospital- and patient-related factors
AU - Duke, Graeme J.
AU - Moran, John L.
AU - Bersten, Andrew D.
AU - Bihari, Shailesh
AU - Roodenburg, Owen
AU - Karnon, Jonathan
AU - Hirth, Steven
AU - Hakendorf, Paul
AU - Santamaria, John D.
PY - 2022/3/21
Y1 - 2022/3/21
N2 - Objective: To quantify the prevalence of hospital-acquired complications; to determine the relative influence of patient- and hospital-related factors on complication rates. Design, participants: Retrospective analysis of administrative data (Integrated South Australian Activity Collection; Victorian Admitted Episodes Dataset) for multiple-day acute care episodes for adults in public hospitals. Setting: Thirty-eight major public hospitals in South Australia and Victoria, 2015–2018. Main outcome measures: Hospital-acquired complication rates, overall and by complication class, by hospital and hospital type (tertiary referral, major metropolitan service, major regional service); variance in rates (intra-class correlation coefficient, ICC) at the patient, hospital, and hospital type levels as surrogate measures of their influence on rates. Results: Of 1 558 978 public hospital episodes (10 029 918 bed-days), 151 486 included a total of 214 286 hospital-acquired complications (9.72 [95% CI, 9.67–9.77] events per 100 episodes; 2.14 [95% CI, 2.13–2.15] events per 100 bed-days). Complication rates were highest in tertiary referral hospitals (12.7 [95% CI, 12.6–12.8] events per 100 episodes) and for episodes including intensive care components (37.1 [95% CI, 36.7–37.4] events per 100 episodes). For all complication classes, inter-hospital variation was determined more by patient factors (overall ICC, 0.55; 95% CI, 0.53–0.57) than by hospital factors (ICC, 0.04; 95% CI, 0.02–0.07) or hospital type (ICC, 0.01; 95% CI, 0.001–0.03). Conclusions: Hospital-acquired complications were recorded for 9.7% of hospital episodes, but patient-related factors played a greater role in determining their prevalence than the treating hospital.
AB - Objective: To quantify the prevalence of hospital-acquired complications; to determine the relative influence of patient- and hospital-related factors on complication rates. Design, participants: Retrospective analysis of administrative data (Integrated South Australian Activity Collection; Victorian Admitted Episodes Dataset) for multiple-day acute care episodes for adults in public hospitals. Setting: Thirty-eight major public hospitals in South Australia and Victoria, 2015–2018. Main outcome measures: Hospital-acquired complication rates, overall and by complication class, by hospital and hospital type (tertiary referral, major metropolitan service, major regional service); variance in rates (intra-class correlation coefficient, ICC) at the patient, hospital, and hospital type levels as surrogate measures of their influence on rates. Results: Of 1 558 978 public hospital episodes (10 029 918 bed-days), 151 486 included a total of 214 286 hospital-acquired complications (9.72 [95% CI, 9.67–9.77] events per 100 episodes; 2.14 [95% CI, 2.13–2.15] events per 100 bed-days). Complication rates were highest in tertiary referral hospitals (12.7 [95% CI, 12.6–12.8] events per 100 episodes) and for episodes including intensive care components (37.1 [95% CI, 36.7–37.4] events per 100 episodes). For all complication classes, inter-hospital variation was determined more by patient factors (overall ICC, 0.55; 95% CI, 0.53–0.57) than by hospital factors (ICC, 0.04; 95% CI, 0.02–0.07) or hospital type (ICC, 0.01; 95% CI, 0.001–0.03). Conclusions: Hospital-acquired complications were recorded for 9.7% of hospital episodes, but patient-related factors played a greater role in determining their prevalence than the treating hospital.
KW - Hospital-acquired complications
KW - iatrogenic harm
KW - hospital-related factors
KW - patient-related factors
KW - Adverse events
KW - Quality of health care
KW - Analysis of variance
KW - Morbidity
UR - http://www.scopus.com/inward/record.url?scp=85122142077&partnerID=8YFLogxK
U2 - 10.5694/mja2.51375
DO - 10.5694/mja2.51375
M3 - Article
AN - SCOPUS:85122142077
VL - 216
SP - 242
EP - 247
JO - Medical Journal of Australia
JF - Medical Journal of Australia
SN - 0025-729X
IS - 5
ER -